Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycine-rich peptide motifs, most notably the (Gly4Ser)n sequence, are synthetic amino acid chains used as flexible linkers in the design of engineered fusion proteins, such as single-chain variable fragments (scFvs), bispecific antibodies, and chimeric antigen receptors (CARs) (Chen et al., 2013). These motifs are characterized by a high glycine content, which provides the necessary rotational freedom for connected protein domains to fold and function independently. While these motifs are critical components of many modern biotherapeutics, they are not considered therapeutic targets in the traditional sense (e.g., receptors or enzymes). Instead, they are structural elements of the drug molecules themselves. A significant challenge associated with these motifs is their potential immunogenicity; patients may develop anti-drug antibodies (ADAs) specifically targeting the linker sequence, which can reduce the drug's half-life or cause adverse immune reactions (Harding et al., 2010). The phrase "outside peptidoglycan linkers" serves to distinguish these synthetic motifs from the natural glycine-rich cross-bridges (e.g., pentaglycine) found in the cell walls of Gram-positive bacteria like Staphylococcus aureus, which are targets for specialized antimicrobial enzymes like lysostaphin (Bastos et al., 2010). This entry is marked as incorrect because the provided name is a descriptive phrase containing a typo ("peptidoglycann") rather than a canonical biological target.
Provides conformational flexibility and structural spacing between functional domains in engineered fusion proteins to ensure proper folding and binding activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycine-rich peptide motif.